Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Adv Therapy

Search In Journal Title:

Abbravation: Advances in Therapy

Search In Journal Abbravation:

Publisher

Springer Healthcare Communications

Search In Publisher:

DOI

10.1016/0378-4274(85)90181-X

Search In DOI:

ISSN

1865-8652

Search In ISSN:
Search In Title Of Papers:

Coma caused by isoniazid poisoning in a patient tr

Authors: WeiPing Tai Hui Yue PinJing Hu
Publish Date: 2008/09/20
Volume: 25, Issue: 10, Pages: 1085-
PDF Link

Abstract

Isoniazid is widely used to treat tuberculosis In populations with a high prevalence rate of tuberculosis acute ingestion of isoniazid has been reported as a potential cause of coma In this study we present the diagnosis and treatment of isoniazid poisoning in a case with acute coma as the major clinical presentationA 32yearold male who ingested 12 g isoniazid 2 hours prior to medical attention was brought to the emergency department while in a coma and experiencing frequent seizures Initial treatment with large doses of pyridoxine for 6 hours failed to awaken this patient The patient was then given hemodialysis and pyridoxine after 3 days he awoke from coma with no further reported seizuresIsoniazid poisoning should be suspected in patients whose major symptoms are coma and seizure especially those who have access to isoniazid Monitoring the blood level of isoniazid will establish the diagnosis and help clinical management A combination of hemodialysis and pyridoxine is effective in treating isoniazid poisoning


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Azacytidine for the treatment of myelodysplastic syndromes in the elderly
  2. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  3. Budget Impact Analysis of a Fixed-Dose Combination of Fluticasone Propionate and Formoterol Fumarate (FP/FORM) in a Pressurized Metered-Dose Inhaler (pMDI) for Asthma
  4. When People with Opioid-Induced Constipation Speak: A Patient Survey
  5. Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study
  6. Sunitinib: the First to Arrive at First-Line Metastatic Renal Cell Carcinoma
  7. Adherence to Long-Term Interferon Beta-1b Injection Therapy in Patients with Multiple Sclerosis Using an Electronic Diary
  8. A 6-Month Study Comparing Efficacy, Safety, and Tolerability of the Preservative-free Fixed Combination of Tafluprost 0.0015% and Timolol 0.5% versus Each of Its Individual Preservative-Free Components
  9. Individualized Fludarabine-Based Regimen in Elderly Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
  10. Broadening the perspective when assessing evidence on boosted protease inhibitor-based regimens for initial antiretroviral therapy
  11. The pharmacodynamic properties of azithromycin in a kinetics-of-kill model and implications for bacterial conjunctivitis treatment
  12. Are Dosing Adjustments Required for Colchicine in the Elderly Compared with Younger Patients?
  13. An Overview of Letrozole in Postmenopausal Women with Hormone-Responsive Breast Cancer
  14. Slovak Trial on Cardiovascular Risk Reduction Following National Guidelines with CaDUET® (The STRONG DUET Study)
  15. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy
  16. Corneal staining reductions observed after treatment with Systane® Lubricant Eye Drops
  17. Cost-Effectiveness of High Dose Hemodialysis in Comparison to Conventional In-Center Hemodialysis in the Netherlands
  18. Advances in Clinical Cardiology
  19. Efficacy and tolerability of eperisone and baclofen in spastic palsy: a double-blind randomized trial
  20. Dose-Finding Study of Landiolol Hydrochloride: A Short-Acting β 1 -Blocker for Controlling Heart Rate During Coronary Computed-Tomography Angiography in Japan
  21. Fluoroquinolone use is not associated with the change in imipenem susceptibility of Pseudomonas aeruginosa in 25 hospitals
  22. Glial fibrillary acidic protein (GFAP) and CD34 expression in the human optic nerve and brain in methanol toxicity
  23. Urapidil, a dual-acting antihypertensive agent: Current usage considerations

Search Result: